Cherishing the 100th Birth Anniversary of Sir James Wyte Black-Pioneer of the First Clinically Significant Beta-Blocker Dr Vilas P. Magarkar14 Jun 2024 11:15 AM ISTThe 100th birth anniversary of Sir James Wyte Black is a momentous occasion to reflect on his monumental contributions to medicine, particularly...
Hypertension Management in Pre- and Post- Percutaneous Coronary Intervention - An Expert Opinion MD Brand Connect10 Jun 2024 11:00 AM ISTAngiotensin receptor blockers (ARBs) are the most preferred antihypertensive agents among Indian cardiologists for managing hypertension in...
Overview Of Ongoing Research And Developments In The Field Of Treating Brain Tumours - Dr G Sudheer Kumar Dr G Sudheer Kumar8 Jun 2024 8:45 AM IST The incidence of central nervous system tumours in India ranges from 5 to 8 per 100,000 population. Tumours of the central nervous system...
Future Directions in Brain Tumor Research and Treatment - Dr Bopanna K M Dr Bopanna K M7 Jun 2024 9:30 AM IST Heterogeneity is probably the most defining factor in addressing the complex topic of brain tumours. Malignant brain tumours are diverse in...
Harmonizing Adult Vaccination Guidelines in India: Need of the Hour (Prof) Dr Agam Vora6 Jun 2024 12:36 PM ISTA. Need for Adult ImmunizationVaccine-preventable diseases (VPDs) are among the various diseases that threaten India's healthcare system. From this...
Combination therapy with ARBs and Beta-blockers for post-PCI patients with hypertension-Expert Opinion of Indian Cardiologists Dr Jeegar Dattani4 Jun 2024 11:00 AM ISTThe expert opinion is the first of its kind, guiding Indian Cardiologists in managing hypertension in post-PCI patients with comorbidities. A total of...
Understanding Inversion: How A Time-Tested Problem-Solving Strategy Transforms Medical Practice and Beyond - Raja Reddy Raja Reddy27 May 2024 3:23 PM IST Throughout my extensive career in Pharmaceutical Sales, I have had the distinct privilege of observing some of India's most esteemed doctors...
Glipizide-Metformin, Glimepiride-Metformin-Pioglitazone FDCs Reduce Medication Costs in Indian T2DM: Study Dr. Kamal Kant Kohli27 May 2024 11:30 AM ISTAffordable combination medicines, such as glipizide + metformin and glimepiride + metformin + pioglitazone offer considerable advantages and can...
Applicability of FDC of Linagliptin and Dapagliflozin in T2DM: EVERGREEN Case Report Summaries Dr Jeegar Dattani24 May 2024 11:00 AM ISTThe EVERGREEN webinar, designed to guide physicians regarding the care of people with diabetes, highlighted the clinical applicability of a...
Complicated Urinary Tract Infections: Current Management Challenges and Need to Look Beyond Dr. Kamal Kant Kohli21 May 2024 11:39 AM ISTKey Messages:Antimicrobial resistance is one of the top global public health threats.Complicated urinary tract infections (cUTIs) are the most common...
Affordable Combinations in T2DM care: Scope of Glipizide, Metformin and Glimepiride, Metformin, Pioglitazone MDTV Bureau20 May 2024 11:31 AM ISTDual therapy of Glipizide + Metformin and the triple drug combination of Glimepiride + Metformin + Pioglitazone emerges as effective, safe, and...
Beta Blockers: A Five-Decade Legacy and Spotlight on Metoprolol Dr. Rajiv Karnik17 May 2024 11:00 AM ISTSince their introduction over five decades ago, beta-blockers have revolutionized the landscape of cardiovascular medicine. Initially developed to...
